Asset
Bezisterim
BioVie Inc. Class A Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04669028 | phase3 | completed | 2021-08-05 | 2023-09-30 | BioVie Inc. | A Phase 3 Study of NE3107 in Probable Alzheimer's Disease |
| NCT06757010 | phase2 | completed | 2025-03-26 | 2026-05-01 | BioVie Inc. | A Study of NE3107 in Early Parkinson's |
| NCT05083260 | phase1_2 | completed | 2022-01-04 | 2022-11-21 | BioVie Inc. | NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa |
| NCT06847191 | phase2 | active_not_recruiting | 2025-04-29 | 2026-08-06 | BioVie Inc. | NE3107 in Adults With Neurological Symptoms of Long COVID |
FDA applications (0)
This company has no applications containing this asset.